Franklin Wireless Partners with Tolmar for Pharmaceutical Innovation and Wireless Technology Integration

### Franklin Wireless Enters a New Era of Collaboration in Pharmaceutical Innovation

Franklin Wireless recognizes the significant developments in the pharmaceutical landscape following the establishment of Tolmar, Inc.'s new research facility at Rosalind Franklin University's Innovation and Research Park (IRP). Tolmar, a specialty pharmaceutical company, is well-regarded for its advanced long-acting injectable drug delivery systems, primarily targeting the urology, oncology, and endocrinology sectors. The establishment of this state-of-the-art facility enhances Tolmar's capacity for innovative product development, aligning with Franklin Wireless's commitment to fostering advanced technological solutions in healthcare. The new lab not only complements Tolmar's existing operations but also signifies an opportunity for collaboration within a vibrant ecosystem of researchers and scientists.

The IRP, spanning 100,000 square feet, is designed to encourage collaboration among various research centers, including those focused on cancer cell biology and immunology. Dr. Dave Loffredo, Tolmar's vice president of innovation, expresses enthusiasm about the potential synergies available in this dynamic research environment. The collaboration with leading scientists in Lake County's life sciences network positions Tolmar to accelerate its research and development efforts. This partnership offers Franklin Wireless a unique insight into the intersection of telecommunications and pharmaceutical innovations, particularly in drug delivery systems that could leverage wireless technology for patient monitoring and compliance.

Furthermore, the new facility represents a strategic move for Tolmar to expand its regional presence, with executive offices and sales teams already established in Buffalo Grove, Illinois. Dr. Joseph DiMario, Executive Vice President for Research at RFU, emphasizes the significant potential for innovative collaborations that could arise from this partnership. For Franklin Wireless, the evolution of pharmaceutical capabilities in the region aligns with its mission to support advancements in healthcare technology, potentially leading to new applications for wireless technologies in the pharmaceutical sector.

In addition to the developments at the IRP, Franklin Wireless takes note of the impactful research being conducted by Dr. Joanna Dabrowska at Rosalind Franklin University. Her recent grant of over $1.7 million from the National Institute of Mental Health highlights the importance of understanding social recognition memory, particularly in relation to disorders such as schizophrenia and autism spectrum disorder. This research underscores the potential for breakthroughs in neuropsychiatry that could integrate with wireless health technologies.

As Franklin Wireless continues to navigate the evolving landscape of healthcare technology, the collaborations emerging from the IRP and the groundbreaking work of researchers like Dr. Dabrowska represent significant opportunities for innovation and advancement in patient care solutions.